Awareness Was the Easy Part
Health Awareness Month doesn’t need another hot take. It needs evidence — and the digital mental health category is finally being forced to produce some.
One number sets the table: as of August 2024, more than one-third of Americans — 122 million people — lived in a federally designated Mental Health Professional Shortage Area. HRSA projects we’ll be short roughly 88,000 mental health counselors, 62,000 psychologists, and 42,000 psychiatrists by 2036. No realistic expansion of the clinical workforce closes that gap. Not training pipelines, not licensure reform, not loan repayment. The math doesn’t work.
That’s the actual context for every conversation about digital mental health (which is May). The question was never whether software has a role. The question is which software, prescribed by whom, paid for how, and with what evidence.
For most of the last decade, the industry has answered those questions badly.
A New Era of Digital Health
The first wave of digital mental health was built on engagement. Downloads, daily active users, streaks, badges. Companies raised billions on metrics that had no relationship to clinical outcomes, and a generation of buyers — employers, payers, health systems — got sold tools that produced impressive dashboards and modest results. The reckoning was inevitable.
It arrived in 2023. Pear Therapeutics, valued at $1.6 billion two years earlier, was sold for parts at auction for $6.05 million. Akili Interactive abandoned the prescription model entirely, went OTC, and sold off its assets in 2024. The cautionary read is that digital therapeutics don’t work. The accurate read is narrower: the first generation got the science roughly right and the business model entirely wrong. Pear’s products were priced above $1,000, targeted some of the hardest-to-treat conditions in medicine, and depended on reimbursement infrastructure that didn’t exist yet.
That infrastructure exists now. In 2025, CMS introduced Digital Mental Health Treatment (DMHT) codes, the first dedicated Medicare reimbursement pathway for the category. Uptake has been uneven — CMS left rate-setting to regional contractors instead of issuing a national rate, and providers unfamiliar with prescribing software are still learning the workflow. But the door is open in a way it has never been. Congress is considering the Access to Prescription Digital Therapeutics Act. The FDA launched the TEMPO pilot in December to accelerate uptake. The plumbing is finally being built.
What separates the next wave from the last one
Three things, and insiders already know them.
Clinical evidence designed for payers, not press releases. Randomized trials, predefined endpoints, durable outcomes — not engagement curves.
A reimbursement strategy that doesn’t require boiling the ocean. The companies that survive will price for the system that exists, not the one they wish existed.
Equity built into design, not bolted on. The behavioral health workforce skews female and non-Hispanic White and is concentrated in urban areas while rural counties lack providers entirely. Digital tools either close that distribution gap or they replicate it. Validation cohorts that look nothing like the patients who need the product are how you build a clinically impressive failure.
Where Rewire fits
Rewire Digital Health is operating in this second wave deliberately. The platform is built on a clinician-supported model rather, with intervention design grounded in established neuroscience and outcomes measured against clinical endpoints.
Rewire has achieved significant scientific and product validation milestones through its Cognitive Modeling Lab partnership at Carleton University, led by Dr. Rob West. Early findings support the company’s core hypothesis: that gameplay-derived cognitive signals can be reliably mapped to depressive cognitive patterns and dynamically targeted through adaptive in-game mechanics.
The reason that matters beyond Rewire is what it signals about the category. The companies that will define digital mental health over the next five years are the ones that took the lessons of Pear and Akili seriously — not as cautionary tales about whether to build, but as instruction on how.
The work, year-round
Share the article:
Learn more about
